Schedule 13D ownership disclosure
INOTEK PHARMACEUTICALS CORP
Security class unavailable · CUSIP: 45780V102
Event date: 2017-09-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.5500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-17-003915
- Form type
- SC 13D
- Filer
- ADAGE CAPITAL PARTNERS GP, L.L.C.
- CIK
- CIK 1165408
- Filed
- Oct 05, 2017
- Reporting period
- Sep 26, 2017
- Description
- Schedule 13D beneficial ownership